VNDA
Vanda Pharmaceuticals Inc. · Healthcare · Market cap $328.3M(Price slightly stale)
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.8M
reported sales (SEC code S)
Unique Insiders
6
in the rolling window
Latest filing
Jun 8, 2026
Williams Timothy
Vanda Pharmaceuticals Inc. (VNDA) has 20 SEC Form 4 filings (20 transaction rows) in the rolling window, disclosed by 6 distinct insiders. Most recent filing: Jun 8, 2026.
Inside the rolling window, 6 insiders at Vanda Pharmaceuticals Inc. reported no open-market purchases and 6 open-market sales totaling $2.8M. Insiders have net sold $2.8M over the trailing 6 months. The most recent open-market filing is a sale of 42,434 shares by SVP & General Counsel Williams Timothy, dated Mar 2, 2026, worth $351K.
- Industry:Biotechnology
- CEO:Mihael H. Polymeropoulos
- Employees:533
- HQ:Washington, DC, US
- IPO:2006-04-12
| Source | |||||||
|---|---|---|---|---|---|---|---|
Williams TimothyFirst filing | SVP & General Counsel | Sale | 42,434 | $351K | Mar 4 | -33.8% | SEC ↗ |
Birznieks GuntherFirst filing | SVP, Business Development | Sale | 42,431 | $351K | Mar 4 | -33.8% | SEC ↗ |
Polymeropoulos Mihael HristosFirst filing | President and CEO | Sale | 156,235 | $1.3M | Mar 4 | -33.8% | SEC ↗ |
Moran Kevin PatrickFirst filing | SVP, CFO & Treasurer | Sale | 42,442 | $351K | Mar 4 | -33.8% | SEC ↗ |
Wijkstrom JoakimFirst filing | SVP, Chief Marketing Officer | Sale | 30,800 | $255K | Mar 4 | -33.8% | SEC ↗ |
Honore TageFirst filing | Director | Sale | 30,000 | $241K | Feb 24 | -33.5% | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does VNDA have?
Vanda Pharmaceuticals Inc. (VNDA) has 20 SEC Form 4 filings (20 transaction rows) in the rolling 365-day window, disclosed by 6 distinct insiders. Most recent filing: Jun 8, 2026.
When was the most recent SEC Form 4 filing for VNDA?
The most recent Form 4 filing for VNDA on Tracefour is dated Jun 8, 2026.
What is the net insider flow at VNDA over the last 6 months?
Over the trailing 180 days, insiders at VNDA have net sold $2.8M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at VNDA in the current window?
Inside the rolling window, insiders at VNDA bought $0 and sold $2.8M based on SEC Form 4 filings.
Can I get alerts for VNDA insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Vanda Pharmaceuticals Inc. (VNDA). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Vanda Pharmaceuticals Inc. is in the Healthcare sector.